• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Samrat Pharmachem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4878.0
  • ISIN : INE103E01016
338.70 -4 (-1.24%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    338.00

  • Today’s High

    349.00

  • Open

    340.00

  • Perv Close

    342.95

  • 52W Low

    302.05

  • 52W High

    646.00

Key Indicators

  • P/E(TTM)

    14.71

  • Mar.Cap (₹Cr.)

    104.65

  • Div & Yield %

    0.30

  • Book Value(₹)

    232.38

  • Debt-Equity Ratio

    -1.24

  • AGM Date

    01-Aug-2025

  • EPS

    23.02

  • P/E Ratio

    14.71

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    104.65

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    232.40

  • Sales( ₹ in Cr.)

    285.86

  • NP (in Cr.)

    7.11

  • NP Var(%)

    231.0

  • Div%

    10.0

  • CPS (₹)

    25.10

  • EPS (₹)

    23.00

  • Traded Value (₹ in Lakhs)

    104.65

  • 52 Week High

    646.00

  • 52 Week Low

    302.05

  • Price BSE

    339.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    104.65

  • P/C Ratio

    13.50

  • P/E Ratio

    14.70

  • Price Vs.BV

    23.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 281.58 310.65 221.75 204.37 157.12 125.36
Excise Duty 0.00 0.00 0.00 25.35 19.66 14.22
Net Sales 281.58 310.65 221.75 179.02 137.46 111.14
Other Income 1.38 0.48 0.63 0.46 0.57 0.46
Stock Adjustments -4.84 10.14 0.33 -2.23 6.18 0.91
Total Income 278.12 321.27 222.71 177.25 144.21 112.51
EXPENDITURE :            
Raw Materials 265.48 288.00 190.23 162.02 131.80 103.53
Power and Fuel Cost 1.37 1.46 1.34 1.12 0.91 0.73
Employee Cost 1.11 1.07 0.96 1.05 1.00 0.94
Other Manufacturing Expenses 2.17 2.47 2.29 1.65 1.34 1.52
Selling and Administration Expenses 3.36 3.10 2.46 1.83 1.83 2.09
Miscellaneous Expenses 0.78 0.76 0.55 0.47 0.13 0.05
Employee Benefit Expenses 1.11 1.07 0.96 1.05 1.00 0.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 274.27 296.85 197.84 168.14 137.02 108.87
Operating Profit 3.86 24.40 24.87 9.12 7.19 3.64
Interest 0.69 1.23 0.67 1.28 0.98 1.06
Gross Profit 3.17 23.17 24.20 7.84 6.21 2.58
Depreciation 0.65 0.64 0.59 0.49 0.43 0.42
Profit Before Tax 2.52 22.53 23.61 7.35 5.78 2.16
Current Tax 0.28 6.11 6.39 1.72 1.73 0.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.08 -0.21 0.03 0.29 -0.18 0.01
Reported Net Profit 2.16 16.63 17.18 5.33 4.24 1.54
Extraordinary Items 0.02 0.00 -0.02 -0.01 -0.01 0.00
Adjusted Net Profit 2.14 16.63 17.20 5.34 4.25 1.54
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 60.05 43.73 26.55 21.21 16.98 15.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.31 0.31 0.00 0.00 0.00 0.00
P & L Balance carried down 61.91 60.05 43.73 26.55 21.21 16.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.00 53.83 55.62 17.26 13.71 4.97
Earnings Per Share(Adj)-Unit Curr 7.00 53.83 55.62 17.26 13.71 4.97
Book Value 210.37 204.37 151.54 95.92 78.66 64.95
Book Value(Adj)-Unit Curr 210.37 204.37 151.54 95.92 78.66 64.95

Shareholding Pattern

  • Promoter Group

    49.09%

  • Public Share Holding

    50.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,516,767 49.09 1,516,767 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,516,767 49.09 1,516,767 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 100,000 3.24 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100,000 3.24 0 1
2] Non Institution
Bodies Corporate 82,677 2.68 81,177 40
Clearing Members 96 0.00 96 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 61,268 1.98 50,868 127
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 41,065 1.33 41,065 103
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 173,757 5.62 173,757 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,112,697 36.01 916,797 6,462
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 572 0.02 572 2
Sub Total 1,472,933 47.67 1,265,133 6,741
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,089,700 100.00 2,781,900 6,752

Company Background

Samrat Pharmachem LtdPharmaceuticals - Indian - Bulk Drugs

  • Samrat Pharmachem Ltd
  • BSE Code : 4878.0
  • ISIN : INE103E01016

  • Incorporation Year

    1992

  • Registered Office

    Plot No A2/3445
    GIDC Phase IV, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-220774

  • FAX

    91-2646-251291

  • Chairman

    Lalit Mehta

  • Managing Director

    Lalit Mehta

  • Company Secretary

    Nishant Kankaria

  • Auditor

    Shah & Savla LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    C-13 Pannalal Silk,
    Mills Cmpd LBS Marg,Bhandup West
    Mumbai - Mumbai - 400 078

Samrat Pharmachem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Samrat Pharma 338.70 282.97 281.58 14.71 4.14
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10